Pactiv Evergreen's Return On Capital Employed Overview
Portfolio Pulse from Benzinga Insights
Pactiv Evergreen (NASDAQ: PTVE) reported Q1 sales of $1.43 billion and a loss of $133 million, a 592.59% decrease from last quarter. The company posted a negative ROCE of -0.09%, suggesting inefficient capital allocation. However, Q1 earnings per share beat analyst predictions at $0.13/share.
May 23, 2023 | 2:54 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pactiv Evergreen reported Q1 sales of $1.43 billion and a loss of $133 million. The company posted a negative ROCE of -0.09%, suggesting inefficient capital allocation. However, Q1 earnings per share beat analyst predictions at $0.13/share.
Pactiv Evergreen's negative ROCE of -0.09% indicates inefficient capital allocation, which could negatively impact the stock price. However, the company's Q1 earnings per share beat analyst predictions, which may offset the negative impact of the ROCE. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100